Impact Biotech Ltd clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   Padeliporfin VTP Treatment for Unresectable Pancreatic…Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

   Primary completion pushed from Aug 30, 2026 to Aug 30, 2027

   Also in this update: Study completion pushed from Oct 30, 2026 to Dec 30, 2027

   Impact Biotech Ltd·Phase 1· NCT05919238· Registry history of NCT05919238 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

2. Notable

   Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral…Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

   Primary completion pushed from May 30, 2027 to Dec 30, 2027

   Also in this update: Enrollment closed, study ongoing

   Impact Biotech Ltd·Phase 1· NCT05918783· Registry history of NCT05918783 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.